mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 2 patents

Readers on

mendeley: 1 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

ß-1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES

Application EP-3582810-A4

European Patent Office

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

Application EP-3247408-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.